Comparison of cardiometabolic risk biomarkers from a national clinical laboratory with the US adult population

Elliott Wolin, Justin White, James V. Pottala, Maciek Sasinowski, Tara Dall, Thomas D. Dayspring, Joseph P. McConnell, Daniel M. Hoefner, Stephen A. Varvel, Dawn L. Thiselton, G. Russell Warnick, William Harris

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

Background Clinical laboratory patient databases are an untapped source of valuable diagnostic and prognostic information. However, the lack of associated clinical and/or demographic information and questionable generalizability to nonpatient populations often limit utility of these data. Objectives This study compared levels of cardiometabolic biomarkers between a national clinical laboratory patient cohort (Health Diagnostic Laboratory [HD Lab]) and the US population as inferred from the National Health and Nutrition Examination Survey (NHANES, 2011-2012). Methods Sample sizes for HD Lab ranged from 199,000 to 739,000 and for NHANES from 2200 to 5300. The latter were weighted to represent the adult US population (∼220 million). Descriptive statistics were compared for body mass index, 5 lipid biomarkers, and 3 glycemic biomarkers. Results Using age- and sex-matched data, mean biomarker values (mg/dL unless noted) and percent differences (%) for HD Lab vs NHANES were body mass index (kg/m2), 29.1 vs 28.6 (1.7%); total cholesterol, 185 vs 193 (-4.1%); apolipoprotein B, 92 vs 90 (2.2%); low-density lipoprotein cholesterol, 107 vs 115 (-7%); high-density lipoprotein cholesterol, 53 vs 53 (0%); triglycerides, 128 vs 127 (0.8%); glucose, 99 vs 108 (-8.3%); insulin (uU/mL), 13.7 vs 13.4 (2.2%); and hemoglobin A1c (%), 5.6 vs 5.8 (-3.4%). Although all differences were statistically significant, only low-density lipoprotein cholesterol and glucose differed by more than 5%. These may reflect a greater use of medications among HD Lab patients and/or preanalytical factors. Conclusions Cardiometabolic risk markers from a national clinical laboratory were broadly similar to those of the US population; thus, with certain caveats, data from the former may be generalizable to the latter.

Original languageEnglish (US)
Pages (from-to)817-823
Number of pages7
JournalJournal of Clinical Lipidology
Volume9
Issue number6
DOIs
StatePublished - Nov 1 2015
Externally publishedYes

Keywords

  • Biomarkers
  • Cardiovascular risk
  • Clinical laboratory
  • Lipids
  • NHANES
  • US population

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine
  • Nutrition and Dietetics

Fingerprint Dive into the research topics of 'Comparison of cardiometabolic risk biomarkers from a national clinical laboratory with the US adult population'. Together they form a unique fingerprint.

  • Cite this

    Wolin, E., White, J., Pottala, J. V., Sasinowski, M., Dall, T., Dayspring, T. D., McConnell, J. P., Hoefner, D. M., Varvel, S. A., Thiselton, D. L., Warnick, G. R., & Harris, W. (2015). Comparison of cardiometabolic risk biomarkers from a national clinical laboratory with the US adult population. Journal of Clinical Lipidology, 9(6), 817-823. https://doi.org/10.1016/j.jacl.2015.07.014